Related Experiment Video

Updated: Mar 22, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.9K

Ovarian Cancer Screening There May Be Light at the End of the Tunnel?

Ranjit Manchanda1, David Cibula

  • 1Department of Gynaecological Oncology St Bartholomew's Hospital Barts Cancer Institute Charterhouse Square London, United Kingdom r.manchanda@qmul.ac.uk Gynecologic Oncology Center Department of Obstetrics and Gynecology First Faculty of Medicine Charles University in Prague General University Hospital in Prague Prague, Czech Republic.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|April 22, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

13.1K
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.6K

Related Experiment Videos

Last Updated: Mar 22, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.9K
Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

13.1K
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.6K

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

3.0K
3.0K
Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K

Articles linked to this work by shared authors, journal, and citation graph.

Risk-Adapted Surveillance in Borderline Ovarian Tumours (BOTs): The "Barts" Evidence-Based Framework.

Cancers·2026

Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial.

The Lancet. Oncology·2026

High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage.

NPJ precision oncology·2026

Health-related quality of life after risk-reducing hysterectomy (PRESCORES): a cross-sectional study.

EClinicalMedicine·2026

Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot.

Nature health·2026

Pre-operative risk stratification in apparent early-stage endometrial cancer using expert ultrasound and molecular classification: a multi-center prospective observational study (PRSTEC_multipro/CEEGOG EX-07).

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Not all artificial intelligence large language models are created equal: heterogeneous performance in therapeutic decision-making for recurrent epithelial ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Early experience with mirvetuximab soravtansine in the treatment of recurrent low- grade serous ovarian carcinoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

BEHOLD-1 and -2: phase 1/2 randomized studies evaluating the B7 homolog 4 protein-targeted antibody-drug conjugate mocertatug rezetecan in patients with solid tumors, including endometrial and ovarian cancers.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Predicting high-grade lesions and cervical cancer with supervised machine learning algorithms.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

PARAGON-II cohort C: a phase II basket study of letrozole plus ribociclib in hormone receptor-positive, platinum-resistant, high-grade epithelial ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Incidence and early prediction of post-operative pancreatic fistula after splenectomy in ovarian cancer cytoreduction within an enhanced recovery after surgery pathway: the ERASPLEEN study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us